M J BIOPHARM PRIVATE LIMITED

Amalgamated

M J BIOPHARM PRIVATE LIMITED having CIN U29249MH1987PTC044458 is 37 years , 9 month & 26 days old Private Indian Company incorporated on 24 Aug 1987. It is classified as Non-government company and is registered at ROC Mumbai. Its authorized share capital is Rs. 200,000,000 and its paid up capital is Rs. 130,100,000. It's NIC code is 29249 (which is part of its CIN).

As per the NIC code, it is involved in Manufacturing Of Machines Used In Construction N.E.C.: Mortar Spreaders . M J BIOPHARM Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 09-29-2017. Directors of M J BIOPHARM are Dhaval Vipin Vashi and Amol Jashwant Shah.

M J BIOPHARM ' Corporate Identification Number (CIN) is U29249MH1987PTC044458 and its registration number is 044458. Users may contact M J BIOPHARM on its Email address - gnalawade123@yahoo.co.in Registered address of M J BIOPHARM is 113 JOLLY MAKER CHAMBERS 2NARIMAN POINT,MUMBAI,Maharashtra,India-400021. Current status of M J BIOPHARM PRIVATE LIMITED is - Amalgamated.

Key Indicators

Authorised Capital

200,000,000

as on 19/06/2025

Paid Up Capital

130,100,000

as on 19/06/2025

Company Age

37 Year, 9 Months

Last Filing with ROC

7 Year, 8 Months

CIN	U29249MH1987PTC044458
Company Status	Amalgamated
Registration Number	044458
Date of Incorporation	08/24/1987
RoC	ROC Mumbai
Company Age	37 years & 309 days
Authorized Capital	₹ 200000000
Paid-up capital	₹ 130100000
Company Category	Company limited by shares
Company Sub-Category	Non-government company
Class of company	Private
Activity	Manufacturing Of Machines Used In Construction N.E.C.: Mortar Spreaders
Listing status	Unlisted
Date of Last Annual General Meeting	31-03-2017
Date of Latest Balance Sheet	31-03-2017

Contact

Email ID	gnalawade123@yahoo.co.in
Address	113 JOLLY MAKER CHAMBERS 2NARIMAN POINT MUMBAI Maharashtra India 400021
Website	yahoo.co.in
Contact Number	+91*******

Location on Map

Director

Designation	Name	Date OF Appointment	DIN	PAN	Tenure
Director	AMOL JASHWANT SHAH	03/16/2023	00171006		2 years
Director	DHAVAL VIPIN VASHI	09/19/2013	06442736	*****5289L	11 years

Companies connected through Directors

Name	Status	Paid Up Capital	Common Directors	Address
FINE FRAGRANCES PRIVATE LIMITED	Active	94,47,940.00	2	Maharashtra
M J INSTITUTE OF RESEARCH PRIVATE LIMITED	Active	1,00,000.00	2	Maharashtra
INNOVA LIFE SCIENCES PRIVATE LIMITED	Active	44,00,000.00	2	Maharashtra
APTEK COMPUTERS PRIVATE LIMITED	Amalgamated	1,00,01,000.00	2	Maharashtra
M J HOLDINGS AND LEASING LTD	Amalgamated	25,00,000.00	2	Maharashtra
CAMLIN FINE SCIENCES LIMITED	Active	18,79,21,012.00	2	Maharashtra
APTEK ELECTRONICS PRIVATE LIMITED	Amalgamated	3,43,000.00	2	Maharashtra
ORGANIC BIOSYSTEMS LLP	Active	0.00	2	-

Charges on assets

CANARA BANK

No. of Loans: 7

Total Amount: 511,152,000.00 cr

ABN Amro Bank N. V.

No. of Loans: 2

Total Amount: 330,000,000.00 cr

EXPORT-IMPORT BANK OF INDIA

No. of Loans: 1

Total Amount: 55,000,000.00 cr

Charge Holder	Branch	Amount	Date of creation	Modification	Satisfaction	Status
CANARA BANK	DALAMAL TOWER	289,000	12 Mar, 2001	-	05 Aug, 2008	Closed
CANARA BANK	DALAMAL TOWER	211,000	08 May, 2000	-	05 Aug, 2008	Closed
ABN Amro Bank N. V.	7th Floor, Nariman Point,	145,000,000	15 Jan, 2009	-	06 May, 2014	Closed
EXPORT-IMPORT BANK OF INDIA	WORLD TRADE CENTRE COMPLEX, CUFFE PARADE,	55,000,000	17 Aug, 2006	15 Jan, 2009	29 Aug, 2012	Closed
ABN Amro Bank N. V.	Sakhar Bhavan, Nariman Point,	185,000,000	25 Jun, 2007	-	06 May, 2014	Closed
CANARA BANK	DALAMAL TOWER	99,500,000	12 Jul, 1999	-	05 Aug, 2008	Closed
CANARA BANK	DALAMAL TOWER	440,000	04 Dec, 1999	-	05 Aug, 2008	Closed
CANARA BANK	DALAMAL TOWER	3,500,000	28 May, 2003	-	05 Aug, 2008	Closed
CANARA BANK	NARIMAN POINT,	1,212,000	11 Jan, 2000	-	05 Aug, 2008	Closed
CANARA BANK	NARIMAN POINT	406,000,000	11 Jan, 1999	14 Feb, 2007	05 Aug, 2008	Closed

Registered Details

CIN

U29249MH1987PTC044458

Incorporation

11 years , 9 month

Company Email

gnalawade123@yahoo.co.in

Paid up Capital

₹ 130,100,000

Authorised Capital

₹ 200,000,000

Type

Private Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

Industry

Manufacturing Of Machines Used In Construction N.E.C.: Mortar Spreaders

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales

0.00%

₹ 0

EBITDA

0.00%

₹ 0

Net Profit

0.00%

₹ 0

Networth

0.00%

₹ 0

Borrowings

0.00%

₹ 0

Assets

0.00%

₹ 0

Gross Margin

0.00%

₹ 0

Operating Margin

0.00%

₹ 0

Net Profit Margin

0.00%

₹ 0

Return on Equity

0.00%

₹ 0

ROCE

9.29%

₹ 140,987.4

Debt to Equity

0.00%

₹ 0

Financial Highlights

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales
Operating profit
Net profit
Gross margin
Operating margin
Net margin
Networth
Borrowings
Assets
Debt to equity
Current ratio
ROE
Days payable
WC days

Balance Sheet

**** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds +
(a) Share capita
(b) Reserves and surplus
(c) Money received against share warrants
(2) Share application money pending allotment
(3) Non-current liabilities +
(a) Long-term borrowings
(b) Deferred tax liabilities (Net)
(c) Other Long-term liabilities
(d) Long-term provisions
(4) Current liabilities +
(a) Short-term borrowings
(b) Trade payables
(A) total outstanding dues of micro enterprises and small enterprises; and
(B) total outstanding dues of creditors other than micro enterprises and small enterprises.
(c) Other current liabilities
(d) Short-term provisions
Total
ASSETS
Non-current assets +
(a) [Property, Plant and Equipment]
(i) Tangible assets
(ii) Intangible assets
(iii)Capital work-in-progress
(iv) Intangible assets under development
(b) Non-current investments
(c) Deferred tax assets (net)
(d) Long-term loans and advances
(e) Other non-current assets
(2) Current assets +
(a) Current investments
(b) Inventories
(c) Trade receivables
(d) Cash and cash equivalents
(e) Short-term loans and advances
(f) Other current assets
Total assets

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds +
(a) Share capita
(b) Reserves and surplus
(c) Money received against share warrants
(2) Share application money pending allotment
(3) Non-current liabilities +
(a) Long-term borrowings
(b) Deferred tax liabilities (Net)
(c) Other Long-term liabilities
(d) Long-term provisions
(4) Current liabilities +
(a) Short-term borrowings
(b) Trade payables
(A) total outstanding dues of micro enterprises and small enterprises; and
(B) total outstanding dues of creditors other than micro enterprises and small enterprises.
(c) Other current liabilities
(d) Short-term provisions
Total
ASSETS
Non-current assets +
(a) [Property, Plant and Equipment]
(i) Tangible assets
(ii) Intangible assets
(iii)Capital work-in-progress
(iv) Intangible assets under development
(b) Non-current investments
(c) Deferred tax assets (net)
(d) Long-term loans and advances
(e) Other non-current assets
(2) Current assets +
(a) Current investments
(b) Inventories
(c) Trade receivables
(d) Cash and cash equivalents
(e) Short-term loans and advances
(f) Other current assets
Total assets

Profit & Loss

**** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
I.Revenue from operations
II. Other income
III.Total Revenue (I + II)
IV.Expenses +
(1)Cost of materials consumed
(2)Purchases of Stock-in-Trade
(3)Changes in inventories of finished goods work-in-progress and
(4)Stock-in-Trade
(5)Employee benefits expense
(6)Finance costs
(7)Depreciation and amortisation expense
(8)Other expenses
(9)Total expenses
VProfit before exceptional and extraordinary items and tax (III - IV)
VIExceptional items
VII.Profit before extraordinary items and tax (V - VI)
VIII.Extraordinary items
IX.Profit before tax (VII- VIII)
X. Tax expense: +
(1)Current tax
(2)Deferred tax
XI.Profit (Loss) for the period from continuing operations (VII-VIII)
XII.Profit/(loss) from discontinuing operations
XIII.Tax expense of discontinuing operations
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII)
XV.Profit (Loss) for the period (XI + XIV)
XVI.Earnings per equity share: +
(1) Basic
(2)Diluted

Precentage of total incomex

Ratio

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency
Total Debt/Equity
Total Debt/Assets
Total Assets/Equity
Liquidity
Current Ratio
Quick Ratio
Interest Coverage
Performance
Gross Margin
Operating Margin
Net Margin
Return
Return on Equity
Pre-tax ROCE
Return on Assets
Pre-tax ROIC
Efficiency
Days Payable
Days Inventory
Days Receivable
Fixed Asset Turnover
Total Asset Turnover
Working Capital
Cash Conversion Cycle
Working Capital Days

Subsidiaries, Associate Companies & Join Ventures of M J Biopharm Private Limited

Company Identifier	Name	Percentage of Shares Held

Fund Raising Activity of M J Biopharm Private Limited

Date of Allotment	Securities Alloted	Terms	Number of Securities	Nominal Amount	Premium Amount Due & Payable	Premium Amount Paid	Total Discount	Amount to be Paid on Calls (Excluding Premium)	Attachments

Board Meetings of M J Biopharm Private Limited

Date of Filing	Date of Dispatch of Notice	Date of Passing Resolution	Section (Companies Act 2013)	Section (Companies Act 1956)	Subject Matter of Resolution	Resolution Agreed By	Resolution Type	Additional Documents

Auditors of M J Biopharm Private Limited

Financial Year	Name of Auditor or Firm	PAN of Auditor or Firm	Membership Number / Registration Number	Name of Auditor Signing Report	Membership Number of Auditor Signing Report

Outstanding Payments to Micro & Small Enterprises

Filing Type	As On	Amount Due to MSME	Current Liabilities	Ratio to Current Liabilities	Reasons for Delay

Investor Complaints & Serious Complaints About M J Biopharm Private Limited

Director Complain

Date	DIN	Cessation Date	Cessation Reason	Complaint

Serious Complaints

Date	Complaint	Other

Investor Complaints & Other Complaints

Date	Complaint Type	Complaint Sub Type	Particulars of Secutiries	Period	Complaint	Other Details

Prosecution Details of M J Biopharm Private Limited

S.No.	Defaulting Entities	Court Name	Prosecution Section	Date of Order	Status

FAQs- M J Biopharm Private Limited

What is M J BIOPHARM PRIVATE LIMITED ?

M J BIOPHARM PRIVATE LIMITED having CIN U29249MH1987PTC044458 is 11 years , 9 month old Private Indian Company incorporated with MCA on 19 Sep 2013. M J BIOPHARM PRIVATE LIMITED is listed in the class of Private Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Mumbai with an Authorized Share Capital of 200,000,000 and paid-up capital is 130,100,000.

What is the CIN of M J BIOPHARM PRIVATE LIMITED?

CIN of M J BIOPHARM PRIVATE LIMITED is U29249MH1987PTC044458.

Where is M J BIOPHARM PRIVATE LIMITED located?

Address of M J BIOPHARM PRIVATE LIMITED is 113 jolly maker chambers 2nariman point,mumbai,maharashtra,india-400021,.

Who are the directors of M J BIOPHARM PRIVATE LIMITED ?

The company has 3 directors/key management personnel Amol Shah,dhaval Vashi,amol Shah,

What is the contact details of M J BIOPHARM PRIVATE LIMITED ?

Email : gnalawade123@yahoo.co.in
Address : 113 JOLLY MAKER CHAMBERS 2NARIMAN POINT MUMBAI Maharashtra India 400021

What does M J BIOPHARM PRIVATE LIMITED do?

M J BIOPHARM PRIVATE LIMITED is involved in activities such as Computer programming, consultancy and related activities

Popular Services

Spice Board registration APEDA Registration Importer Exporter Code Registration AD Code Registration ESI Registration FSSAI Registration FCRA Registration FCRA Registration for Trusts FCRA Registration for Societies FCRA Registration for Section 8 Company Import Export Code Import Export Code Process NSIC Registration Private Limited Company Limited Liability Partnership Partnership Firm One Person Company Startup India Registration PF Registration Director KYC Auditor's Appointment Director's Appointment Net worth Certificate Labour License LLP Annual Compliance Filing